These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2455913)

  • 1. Potential advances in combination chemotherapy for advanced testicular cancer.
    Kaye SB; Stoter G; Sleijfer D; Jones W; Ten Bokkel Huinink W; Splinter T; Van Oosterom A; Harris A; Boven E; De Pauw M
    Prog Clin Biol Res; 1988; 269():461-9. PubMed ID: 2455913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study.
    Kaye SB; Mead GM; Fossa S; Cullen M; deWit R; Bodrogi I; van Groeningen C; Sylvester R; Collette L; Stenning S; De Prijck L; Lallemand E; deMulder P
    J Clin Oncol; 1998 Feb; 16(2):692-701. PubMed ID: 9469359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The modification of the toxicity produced by chemotherapy in testicular cancer by adapting its intensity to prognostic groups].
    Blanco Guerrero R; Germà Lluch JR; Climent Durán MA; Mercedes Ramírez A; Alonso Muñoz C; López Pousa A; López López JJ
    Med Clin (Barc); 1991 Oct; 97(13):491-4. PubMed ID: 1721988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifosfamide in testicular cancer: the Indiana University experience.
    Loehrer PJ; Williams SD; Einhorn LH
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):96-101. PubMed ID: 2539649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of metastatic testicular carcinoma according to prognosis; new development].
    de Wit R; Stoter G
    Ned Tijdschr Geneeskd; 2001 Jun; 145(25):1194-9. PubMed ID: 11447874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of chemotherapy and salvage surgery for advanced testicular cancer].
    Saiki S; Meguro N; Maeda O; Kinouchi T; Kuroda M; Usami M; Kotake T; Miki T
    Hinyokika Kiyo; 1999 Nov; 45(11):777-81. PubMed ID: 10637743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of good risk germ-cell tumours.
    Troost MM; Sternberg CN; de Wit R
    BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer.
    de Wit R; Stoter G; Sleijfer DT; Neijt JP; ten Bokkel Huinink WW; de Prijck L; Collette L; Sylvester R
    Br J Cancer; 1998 Sep; 78(6):828-32. PubMed ID: 9743309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The current management of testicular cancer].
    Kotake T; Miki T
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):195-204. PubMed ID: 2449134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testicular cancer: an oncological success story.
    Einhorn EH
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2630-2. PubMed ID: 10068265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advanced germinal tumors of the testicle: clinical experience with cisplatin, bleomycin and vinblastine (PVB) or etoposide (BEP)].
    Alonso Curbera G; González-Manzano R; Aramendía Beitia JM; Martínez Monge R; Agüera Fernández L; Rebollo Liceaga J
    Rev Med Univ Navarra; 1993; 38(1):13-8. PubMed ID: 8711305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Refractory germ cell cancer of testis treated by salvage high-dose chemotherapy: report of three cases].
    Tanji S; Obara W; Sugimura J; Ohmori S; Matsushita Y; Tokunaga H; Konda R; Fujioka T; Murai K; Ishida Y
    Hinyokika Kiyo; 2004 Feb; 50(2):77-80. PubMed ID: 15101160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-dose chemotherapy with autologous bone marrow transplantation or peripheral blood stem cell transplantation--testicular cancer].
    Miyanaga N; Akaza H
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1771-6. PubMed ID: 7574808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
    Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
    Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
    Rick O; Siegert W; Beyer J
    Cancer Treat Rev; 2001 Oct; 27(5):283-8. PubMed ID: 11871864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
    Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
    J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
    Ikeda I; Shuin T; Yao M; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1993 Mar; 39(3):237-42. PubMed ID: 7685142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ifosfamide in testicular cancer.
    Schmoll HJ
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):82-95. PubMed ID: 2649987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.